Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 4:49 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 75 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Wound, Non-Healed Clear all

Conditions: Obstructive Sleep Apnea, Non-healing Wounds
Interventions: Not listed
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Diabetic Foot Ulcer, Venous Leg Ulcer, Pressure Ulcer, Wound, Non-Healed
Interventions: DETEC® pH; Diagnostic Test
Lead sponsor: Progenitec Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Lake Success, New York • Arlington, Texas

Conditions: Pressure Ulcer
Interventions: AutoloGel; Device
Lead sponsor: Cytomedix; Industry
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Pascagaula, Mississippi

Conditions: Pressure Ulcer
Interventions: PRP Concepts Fibrin Bio-Matrix, Usual and Customary Practice; Device · Other
Lead sponsor: PRP Concepts, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Diabetic Foot Ulcers, Diabetic Foot Wounds
Interventions: Collagenase Santyl Ointment, Placebo Comparator; Biological · Other
Lead sponsor: Healthpoint; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Pressure Ulcer
Interventions: Aurix; Device
Lead sponsor: Nuo Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 22
States / cities: Arcadia, California • Montebello, California • Visalia, California + 16 more

Conditions: Non-healing Wound
Interventions: CeFAZolin Injectable Solution; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Diabetic Foot Infection, Non-healing Wound, Non-healing Diabetic Foot Ulcer
Interventions: TTAX01, Standard Care; Biological · Other
Lead sponsor: BioTissue Holdings, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 16
States / cities: San Francisco, California • Sylmar, California • Miami, Florida + 13 more

Conditions: Venous Leg Ulcer, Venous Ulcer, Venous Stasis Ulcer, Venous Stasis, Wound Heal, Wounds, Venous Insufficiency of Leg, Non-healing Wound
Interventions: TR987 0.1% gel + Standard of Care, Standard of care; Drug · Other
Lead sponsor: TR Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 312 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 33
States / cities: Tucson, Arizona • Castro Valley, California • Fresno, California + 27 more

Conditions: Non-healing Wound, Diabetic Foot Ulcer
Interventions: AC5® Advanced Wound System, Fibracol Plus Collagen Dressing; Device
Lead sponsor: Arch Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: Greenville, North Carolina • Circleville, Ohio

Conditions: Non-Healing Ulcer of Skin, Autofluorescence Imaging
Interventions: MolecuLight; Device
Lead sponsor: Wound Care Plus, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 193 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Blue Springs, Missouri

Conditions: Venous Leg Ulcer
Interventions: allo-APZ2-CVU, Placebo; Drug
Lead sponsor: RHEACELL GmbH & Co. KG; Industry
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 4
States / cities: Hialeah, Florida • Miami, Florida • Boston, Massachusetts + 1 more

Conditions: Non-healing Soft Tissue Wounds
Interventions: Procellera; Drug
Lead sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine; Other
Eligibility: 18 Years to 99 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Diabetic Foot Ulcer
Interventions: Vaporous Hyperoxia Therapy; Device
Lead sponsor: Vaporox; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 3
States / cities: Castle Rock, Colorado • Denver, Colorado

Conditions: Ulcer Healing, Diabetic Foot Ulcer
Interventions: human keratin graft; Device
Lead sponsor: ProgenaCare Global, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 3
States / cities: Miami, Florida • Frederick, Maryland • Salem, Virginia

Conditions: Wounds, Hidradenitis Suppurativa, Hidradenitis, Acne Inversa
Interventions: Not listed
Lead sponsor: George Washington University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 743 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2022
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Pyoderma Gangrenosum
Interventions: Bimekizumab; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Chronic Diabetic Foot Ulcers, Diabetic Neuropathic Ulcers, Non Healing Wound
Interventions: Timolol, Non biologically active gel; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Diabetic Foot Ulcer
Interventions: Oasis, Standard; Device · Other
Lead sponsor: Healthpoint; Industry
Eligibility: 18 Years and older
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 16
States / cities: Little Rock, Arkansas • Carlsbad, California • Fair Oaks, California + 12 more

Conditions: Diabetic Foot Ulcer
Interventions: Dual-layer perinatal tissue allograft, Three-layer fenestrated perinatal tissue allograft, Standard of care; Other
Lead sponsor: Samaritan Biologics; Industry
Eligibility: 18 Years and older
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Monroe, North Carolina

Conditions: Diabetic Foot Ulcer (DFU), Chronic Foot Ulcers
Interventions: Allograft; Other
Lead sponsor: Tides Medical; Industry
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 9
States / cities: Fresno, California • Los Angeles, California • Vista, California + 5 more

Conditions: Venous Leg Ulcer, Venous Ulcer, Venous Stasis Ulcer, Venous Stasis, Wound Heal, Wound, Venous Insufficiency of Leg, Non-healing Wound
Interventions: TR987 0.1% gel + Standard of Care, Standard of care; Drug · Other
Lead sponsor: TR Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 312 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 4
States / cities: Jacksonville, Florida • Clinton Twp, Michigan • Lake Success, New York + 1 more

Conditions: Foot Ulcer, Diabetic
Interventions: DERMASEAL, Plasma Film, Standard of Care; Combination Product · Biological · Other
Lead sponsor: Vitruvian Medical Devices, Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 4
States / cities: Fresno, California • South Miami, Florida • Boardman, Ohio + 1 more

Conditions: Venous Leg Ulcer, Chronic Non-Healing Cutaneous Wounds, VLU
Interventions: LUT017 gel; Drug
Lead sponsor: Antoni Ribas; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Search by objective public record fields.

The Prevalence and Implications of Obstructive Sleep Apnea in the Population of a Wound Center

DETEC® pH Point of Care Wound Diagnostic Test

AutoloGel Therapy to Usual and Customary Care in Pressure Ulcers

A Prospective, Randomized Clinical Trial of PRP Concepts Fibrin Bio-Matrix in Chronic Non-Healing Pressure Ulcers

Wound Edge Changes Following Treatment With Santyl

Effectiveness of Aurix Therapy in Pressure Ulcers

Antibiotic Tumescent For Chronic Wounds

Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU)

Tissue Repair Gel in Venous Leg Ulcers (US)

Use of AC5® Advanced Wound System in the Treatment of Diabetic Foot Ulcers

Retrospective Database Review at LTC and SNFs

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III)

Clinical and Mechanistic Demonstration of a Bioelectric Dressing System for Non-healing Wound Management: A Phase II Trial

Effectiveness of Vaporous Hyperoxia Therapy (VHT) in the Treatment of Chronic Diabetic Foot Ulcers

Evaluating The Efficacy Of A Keratin Graft In Treating Non-Healing Diabetic Foot Ulcers

Wound Etiology and Healing Study

Efficacy of Bimekizumab in Adults With Pyoderma Gangrenosum

Beta Adrenergic Antagonist for the Healing of Chronic DFU

Study of Oasis Ultra in Diabetic Foot Ulcers

Evaluating the Efficacy of Perinatal Membrane Allografts in Addition to the Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers.

Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers

Tissue Repair Gel in Venous Leg Ulcers in AU/US

Study to Assess the Safety of DERMASEAL for Diabetic Foot Ulcers

LUT017 Gel for Venous Leg Ulcers and Chronic Non-Healing Skin Wounds in Adults